You will automatically be redirected in 10 seconds. Or, you can click the link below:

https://www.streetinsider.com/Corporate+News/Regulus+Therapeutics+%28RGLS%29+Announces+Positive+Topline+Data+from+First+Cohort+of+Patients+in+its+Phase+1b+MAD+Clinical+Trial+of+RGLS8429+for+Treatment+of+ADPKD/22179784.html